Purchase Order 75N94020P00318

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $17,525.75 on March 2, 2016, for on-site field service engineer labor supporting reinstallation work. The order carries a firm fixed price and concludes January 31, 2021. Work is performed in San Diego, California.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $12,061.94 on November 20, 2019 for instrument relocation services. Place of performance is San Diego, California. The order, issued as a firm fixed-price purchase order with no set-aside designation, de-obligates expired contract lines. The ultimate completion date is December 31, 2019.</p>

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. for $17,012.48 on April 22, 2019. The order carries a firm fixed price structure and ultimate completion date of April 21, 2020. Performance takes place in San Diego, California. The purchase order procures sequencing instruments, reagents, consumables, or bioinformatics software from Illumina's portfolio—the specific line items are not itemized in the source. No set-aside was used.

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. valued at $7,882.56 on March 29, 2016. The order is firm fixed price with no set-aside designation. Place of performance is San Diego, California. The order expired on April 24, 2016. No further details regarding the specific items or services procured are provided in the source material.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a $7,225.59 delivery order to Illumina, Inc. on April 19, 2016, on a firm fixed-price basis.</p> <p>Place of performance is San Diego, CA 92122. The ultimate completion date is September 2, 2020. No set-aside was used for this order.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to Illumina, Inc. on February 28, 2018, for reagents and flow-cells with a ceiling value of $13,653.72.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price with no set-aside designation.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to Illumina, Inc. on August 16, 2017, for reagents, with a ceiling value of $99,648.67.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases awarded a purchase order to Illumina, Inc. on June 28, 2018, for $14,026.27, with ultimate completion on August 23, 2018. The order covers service agreement support for CBOT and HiSeq sequencers at the agency's Bethesda, Maryland facility. Pricing is firm fixed.</p>

<p>The National Institute of Diabetes and Digestive and Kidney Diseases issued a delivery order to Illumina, Inc. on September 26, 2019, for reagents and consumables with a ceiling value of $500,027.24.</p> <p>Place of performance is San Diego, CA 92122. The order was firm fixed price with an ultimate completion date of November 2, 2020. No set-aside was used.</p>

The Department of Health and Human Services National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $14,074 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the contract, Illumina will provide unspecified products or services to NIH/NIDDK in support of the agency's biomedical research efforts. The contract has a period of performance of just over one year, running from April 20, 2018 through April 11, 2019. No...